Overview

Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with traumatic brain injury and cognitive impairment.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Rivastigmine